These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 23448654)
21. A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Gao F; He T; Wang H; Yu S; Yi D; Liu W; Cai Z Can J Cardiol; 2007 Sep; 23(11):891-8. PubMed ID: 17876381 [TBL] [Abstract][Full Text] [Related]
22. CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging. Schuleri KH; Centola M; Choi SH; Evers KS; Dawoud F; George RT; Lima JA; Lardo AC JACC Cardiovasc Imaging; 2011 Dec; 4(12):1284-93. PubMed ID: 22172785 [TBL] [Abstract][Full Text] [Related]
23. Umbilical cord mesenchymal stromal cells engraft and transdifferentiate into cardiomyocyte-like cells following acute myocardial ischemia⋆. Yigman Z; Ozdemir ED; Turan NN; Ulus AT; Can A Acta Histochem; 2020 Sep; 122(6):151578. PubMed ID: 32778240 [TBL] [Abstract][Full Text] [Related]
24. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats. Cui X; Wang H; Guo H; Wang C; Ao H; Liu X; Tan YZ Tohoku J Exp Med; 2010 Feb; 220(2):139-47. PubMed ID: 20139665 [TBL] [Abstract][Full Text] [Related]
25. Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction. Li Q; Turdi S; Thomas DP; Zhou T; Ren J Toxicol Lett; 2010 Jun; 195(2-3):119-26. PubMed ID: 20303399 [TBL] [Abstract][Full Text] [Related]
26. An electrically coupled tissue-engineered cardiomyocyte scaffold improves cardiac function in rats with chronic heart failure. Lancaster JJ; Juneman E; Arnce SA; Johnson NM; Qin Y; Witte R; Thai H; Kellar RS; Ek Vitorin J; Burt J; Gaballa MA; Bahl JJ; Goldman S J Heart Lung Transplant; 2014 Apr; 33(4):438-45. PubMed ID: 24560982 [TBL] [Abstract][Full Text] [Related]
27. Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue. Gao S; Jin Y; Ma J; Wang J; Wang J; Shao Z; Fan T; Zhang M; Chang D Stem Cell Res Ther; 2022 Jun; 13(1):252. PubMed ID: 35690871 [TBL] [Abstract][Full Text] [Related]
28. An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: a translational approach: Vu and Pal "Myocardial Repair: PRP, Hydrogel and Supplements". Vu TD; Pal SN; Ti LK; Martinez EC; Rufaihah AJ; Ling LH; Lee CN; Richards AM; Kofidis T Biomaterials; 2015 Mar; 45():27-35. PubMed ID: 25662492 [TBL] [Abstract][Full Text] [Related]
29. A prostacyclin agonist and an omental flap increased myocardial blood flow in a porcine chronic ischemia model. Yajima S; Miyagawa S; Fukushima S; Sakai Y; Isohashi K; Watabe T; Ikeda H; Horitsugi G; Harada A; Sakaniwa R; Hatazawa J; Sawa Y J Thorac Cardiovasc Surg; 2018 Jul; 156(1):229-241.e14. PubMed ID: 29627179 [TBL] [Abstract][Full Text] [Related]
30. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats. Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic contribution of stem cell scaffolding in acute injured myocardium. Qian L; Shim W; Gu Y; Shirhan M; Lim KP; Tan LP; Lim CH; Sin YK; Wong P Tissue Eng Part A; 2012 Aug; 18(15-16):1652-63. PubMed ID: 22607369 [TBL] [Abstract][Full Text] [Related]
32. Functional capacity in a rat model of heart failure: impact of myocardial infarct size. Hentschke VS; Capalonga L; Rossato DD; Perini JL; Alves JP; Quagliotto E; Stefani GP; Karsten M; Pontes M; Dal Lago P Exp Physiol; 2017 Nov; 102(11):1448-1458. PubMed ID: 28841254 [TBL] [Abstract][Full Text] [Related]
33. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Boomsma RA; Swaminathan PD; Geenen DL Int J Cardiol; 2007 Oct; 122(1):17-28. PubMed ID: 17187879 [TBL] [Abstract][Full Text] [Related]
34. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860 [TBL] [Abstract][Full Text] [Related]
35. mi R -15a/15b Cluster Modulates Survival of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy of Myocardial Infarction. Tu Y; Qiu Y; Liu L; Huang T; Tang H; Liu Y; Guo W; Jiang H; Fan Y; Yu B J Am Heart Assoc; 2019 Jan; 8(1):e010157. PubMed ID: 30616426 [TBL] [Abstract][Full Text] [Related]
36. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium. Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633 [TBL] [Abstract][Full Text] [Related]